Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatropin for Patellar Tendinopathy
NCT02597660Phase 2Withdrawn
- Sponsor
- Hospital for Special Surgery
- Start
- May 2020
- Primary completion
- Dec 2020
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of somatropin in patellar tendinopathy, sponsored by Hospital for Special Surgery. Planned start May 2020; status: withdrawn.
02
Drugs
somatropin
03
Conditions
patellar tendinopathy
Beyond the preview
Go deeper on NCT02597660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02597660.